Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Smolarz

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1992
Double bolus administration of the novel recombinant plasminogen activator BM 06.022 improves coronary blood flow after reperfusion in a canine model of coronary thrombosisU Martin, G Sponer, R König, et al.
International Journal of Cardiology|August 12, 1998
Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patencyR Meierhenrich, J Carlsson, E Seifried, et al.
Clinical Radiology|December 11, 2007
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patientsS Bisdas, N Chambron Pinho, A Smolarz, et al.
Deutsche Medizinische Wochenschrift (1946)|September 23, 1983
[Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation]P Weller, U Peters, H A Dickmanns, et al.
Clinical Cardiology|May 1, 1991
Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failureB Rauch, R Zimmermann, M Kapp, et al.
The American Journal of Cardiology|September 1, 1993
Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarctionU Tebbe, R von Essen, A Smolarz, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1992
Double bolus administration of the novel recombinant plasminogen activator BM 06.022 improves coronary blood flow after reperfusion in a canine model of coronary thrombosisU Martin, G Sponer, R König, et al.
International Journal of Cardiology|August 12, 1998
Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patencyR Meierhenrich, J Carlsson, E Seifried, et al.
Clinical Radiology|December 11, 2007
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patientsS Bisdas, N Chambron Pinho, A Smolarz, et al.
Deutsche Medizinische Wochenschrift (1946)|September 23, 1983
[Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation]P Weller, U Peters, H A Dickmanns, et al.
Clinical Cardiology|May 1, 1991
Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failureB Rauch, R Zimmermann, M Kapp, et al.
The American Journal of Cardiology|September 1, 1993
Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarctionU Tebbe, R von Essen, A Smolarz, et al.
Pageof 2